NCT00254735View on ClinicalTrials.gov

Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

March 31, 2006

Conditions

Obsessive Compulsive Disorder

Interventions

DRUG

quetiapine fumarate

DRUG

SSRI/Clomipramine

Trial Locations (2)

Unknown

Research Site, Freiburg im Breisgau

Research Site, Lübeck

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY